TherapeuticsMD
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
951 W Yamato Rd Ste 220, Boca Raton, Flo...Phone Number
(561) 961-1900Website
www.therapeuticsmd.comRevenue
<$5 MillionStock Symbol
TXMDIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About TherapeuticsMD
TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The company is committed to advancing the health of women and championing awareness of their healthcare issues. Headquartered in Boca Raton, Florida.Explore more
TherapeuticsMD Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TherapeuticsMD your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if TherapeuticsMD is spiking on competitors!
Click to see if TherapeuticsMD had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
TherapeuticsMD, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at TherapeuticsMD
Funding: Get notified immidiatlly once TherapeuticsMD has new funding data
Website visits: Recent activity has been detected on your website
Check if TherapeuticsMD has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when TherapeuticsMD launches new products
Earning: See what the market has to say on TherapeuticsMD recently announced quarterly report
Recommended Actions
Find VP level buyers at TherapeuticsMD
Find more new buyers
Compare Similar Companies to TherapeuticsMD
Compare insights from companies similar to TherapeuticsMD, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TherapeuticsMD is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
TherapeuticsMD is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about TherapeuticsMD.
TherapeuticsMD financials insights
Gather financial insights about TherapeuticsMD, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$42.8M
2015
Stock Offering
$59.1M
Stock Offering
$32.2M
2016
Stock Offering
$144M
2017
Stock Offering
$68.5M
2018
Stock Offering
$90M
2019
Debt
$300M
Stock Offering
$77M
2022
Private Equity
$15M
TherapeuticsMD Tech Stack
A closer look at the technologies used by TherapeuticsMD
See more technologies
Most Recent Scoops
Earnings
Financial Planning, Product Management, Intellectual Property
Earnings
Financial Planning
Earnings
Financial Planning
Earnings
Asset Management, Financial Planning, Sales
Earnings
Branding, Financial Planning, Workforce Management
TherapeuticsMD News & Media
TherapeuticsMD Announces Full Year 2024 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2024. Full Year 2024 Financial Results Net Loss from Continuing Operations Net loss from continuing operations was $(2.3) million, or $(0.20) per basic and diluted common share, a decrease of $5.4 million, compared to net loss from continuing operations of $(7.7) mTherapeuticsMD Announces Third Quarter 2024 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Results Net Income (Loss) from Continuing Operations Net loss from continuing operations was $(567) thousand, or $(0.05) per basic and diluted common share, compared to a net loss of $(1.4) million, or $(0.13) per basic and dTherapeuticsMD Announces Second Quarter 2024 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Results Net Income (Loss) from Continuing Operations Net loss from continuing operations was $(1.05) million, or $(0.09) per basic and diluted common share, compared to a net loss of $(2.4) million, or $(0.24) per basic and diluTherapeuticsMD Announces First Quarter 2024 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Net Income (Loss) from Continuing Operations Net loss from continuing operations was $(0.8) million, or $(0.07) per basic and diluted common share, compared to net loss from continuing operations of $(2.3) million, or $(0
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TherapeuticsMD
Sign Up For FreeTo access detailed company insights
TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and men... Read More
